The Official
Website of the
International
Sailing Federation

www.sailing.org
11 July 2008, 01:26 pm
Important Notice For Beijing Olympians Taking Beta-2 Agonists
Anti-doping image
The anti-doping effort at the Beijing Olympic Games will be more extensive than ever

Beijing 2008 Olympic Games

If you are an athlete going to the 2008 Olympic Sailing Competition and taking Beta-2 Agonists for ASTHMA or EXERCISE INDUCED ASTHMA (EIA) or EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB) there are important new measures in the IOC Anti-Doping Rules for the Beijing 2008.
The anti-doping measurers at the 2008 Beijing Olympic Games will be tougher than ever and sailors must make sure they fully understand the new IOC Anti-Doping Rules for the Games.

Click here to download the International Olympic Committee Anti-Doping Rules applicable to the Games of the XXIX Olympiad, Beijing 2008.

Please note, the guide below is just one issue being highlighted by ISAF. IT IS THE RESPONSIBILITY OF THE SAILOR TO ENSURE THEY COMPLY WITH ALL AREAS OF THE IOC ANTI-DOPING RULES FOR BEIJING 2008.

Asthma and the 2008 Olympic Games

Information for athletes going to the 2008 Olympic Sailing Competition and taking Beta-2 Agonists for ASTHMA or EXERCISE INDUCED ASTHMA (EIA) or EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB).

Even if they have an Abbreviated Therapeutic Use Exemptions (ATUE) issued by ISAF or their NADO all athletes taking Beta 2 Agonists - salbutamol, salmeterol, formoterol and terbutaline for example - must obtain approval for use during the Olympic Games (27 July 2008 to 24 August 2008) from the IOC Medical Commission.

Athletes who request permission to inhale a Beta 2 Agonist during the 2008 Olympic Games will be required to submit test results to confirm that the athlete has objective evidence of asthma and/or EIA or EIB.

Applications must be addressed to the IOC Medical and Scientific Department using their on-line Therapeutic Use Exemption request form found on www.olympic.org/atue.

The doping control laboratory will report the presence in urine of any Beta 2 Agonist. For any athlete who has not received an authorisation from the IOC Medical Commission to inhale a Beta 2 Agonist(s), or who has not respected an approval granted to use any of these substances, the result of the doping control will be considered as an adverse analytical finding. The procedures in place for an adverse analytical finding will then be applied. For any questions related to the on-line form, please contact the IOC Medical and Scientific Department by e-mail at beta2@olympic.org or by telephone on + 41 21 621 6111.

Click here for the IOC Guidelines for Beta 2 Agonist Use in Beijing.

During the 2008 Olympic Games if an athlete develops asthma they should attend the nearest Polyclinic, apply for an ATUE prior to administering an inhaled beta 2 agonist.

ISAF Olympic Games microsite - www.sailing.org/olympics
ISAF
Share this page
Isaf TV
Latest News
News Archive
© 2014 Copyright ISAF/ISAF UK Ltd. All Rights Reserved Privacy & Cookies delivered by Sotic powered by OpenText WSM